Abstract:
Objective To assess the risk of public health emergencies that may occur or be imported from abroad in China (except Hong Kong and Macao Special Administrative Regions and Taiwan province, the same below) in April 2024.
Methods Based on various data and departmental notification information on domestic and foreign public health emergencies reports and surveillance of key infectious diseases, the expert consultation method was used and experts from provincial (autonomous regions and municipalities directly under the central government) centers for disease control and prevention were invited to participate in the assessment by video conference.
Results It is predicted that the incidence of public health emergencies in April 2024 would be at the same level as that in March 2024. The main public health emergencies would be infectious diseases. The prevalence of pertussis might continue to rise. The incidence of severe fever with thrombocytopenia syndrome may enter a rapid rise period. The incidence of JN.1 variant of COVID-19 in China has shown a decline trend and would continue to decline in April. It is in the early stage of the epidemic of hand, foot and mouth disease (HFMD) currently, and the number of cases is predicted to increase in April. The risk of imported and local transmission in China of Oropche fever epidemic is low.
Conclusion Closed attention should be paid to pertussis, severe fever with thrombocytopenia syndrome and COVID-19, and general attention should be paid to HFMD, and Oropche fever.